XRAY: 分析师目标 $15 — AI 分析 (4月 2026)

DENTSPLY SIRONA Inc. is a global manufacturer and seller of dental products and technologies, operating through Technologies & Equipment and Consumables segments. The company offers a wide range of solutions for dental professionals worldwide.

Key Facts: Price: $11.54 Analyst Target: $15.00 AI Score: 48/100 Sector: Healthcare

公司概况

概要：

DENTSPLY SIRONA (XRAY) offers a comprehensive suite of dental solutions, from equipment to consumables, holding a significant position in the global dental market with a broad product portfolio and established distribution network, presenting a compelling opportunity for long-term growth despite current profitability challenges.

XRAY是做什么的？

Founded in 1877 and headquartered in Charlotte, North Carolina, DENTSPLY SIRONA Inc. has evolved into one of the world's largest manufacturers of professional dental products and technologies. The company operates through two primary segments: Technologies & Equipment and Consumables. The Technologies & Equipment segment provides a wide array of dental equipment, including treatment centers, imaging equipment, and CAD/CAM technologies, enabling dental practitioners to perform various digital dental procedures. This segment also includes dentist-directed clear aligner solutions (SureSmile) and direct-to-consumer clear aligner solutions. The Consumables segment offers a comprehensive range of products, such as endodontic solutions, restorative materials, and small equipment products like intraoral curing light systems and dental diagnostic systems. DENTSPLY SIRONA's products are used by dentists, specialists, and dental laboratories worldwide, making it a key player in the global dental market. The company's extensive product portfolio and global distribution network provide a strong foundation for continued growth and innovation in the dental industry.

XRAY的投资论点是什么？

Investing in DENTSPLY SIRONA (XRAY) presents a compelling opportunity based on its established market position and potential for future growth. While the company currently faces profitability challenges, as reflected in its negative P/E ratio of -3.11 and a negative profit margin of -24.3%, its strong gross margin of 50.9% indicates underlying pricing power. The company's dividend yield of 4.65% offers an attractive income stream while investors await a turnaround. Key value drivers include the increasing adoption of digital dentistry, the growing demand for cosmetic dental procedures, and the company's ability to innovate and introduce new products. The company's beta of 1.02 suggests market-average volatility. Successful execution of strategic initiatives and improved operational efficiency could drive significant upside potential.

XRAY在哪个行业运营？

DENTSPLY SIRONA operates in the global dental market, which is characterized by increasing demand for advanced dental technologies and cosmetic procedures. The market is driven by an aging population, rising disposable incomes, and growing awareness of oral health. The competitive landscape includes companies like AGIO, BEAM, BHC, CON, and HAE, each vying for market share with different product portfolios and geographic focuses. DENTSPLY SIRONA's broad product range and established distribution network position it well to capitalize on these trends, although it faces competition from both established players and emerging disruptors.

Medical - Instruments & Supplies

Healthcare

XRAY有哪些增长机遇？

Expansion in Digital Dentistry: The increasing adoption of digital dentistry presents a significant growth opportunity for DENTSPLY SIRONA. The market for digital dentistry solutions, including CAD/CAM systems and imaging equipment, is projected to grow substantially over the next five years. By investing in and promoting its digital solutions, DENTSPLY SIRONA can capture a larger share of this expanding market.
Growth in Emerging Markets: Emerging markets, such as China and India, offer substantial growth potential due to their large populations and increasing access to dental care. DENTSPLY SIRONA can expand its presence in these markets by establishing local partnerships, tailoring its product offerings to meet local needs, and investing in sales and marketing efforts.
Innovation in Clear Aligner Therapy: The clear aligner market is experiencing rapid growth, driven by increasing demand for discreet orthodontic solutions. DENTSPLY SIRONA's SureSmile clear aligner system provides a competitive offering in this market. Continued innovation and marketing efforts can drive further adoption and market share gains.
Development of Advanced Materials: The development and introduction of advanced dental materials, such as high-strength ceramics and biocompatible polymers, can drive growth by offering improved performance and aesthetics. DENTSPLY SIRONA can invest in research and development to create innovative materials that meet the evolving needs of dental professionals.
Strategic Acquisitions: Strategic acquisitions can provide DENTSPLY SIRONA with access to new technologies, products, and markets. By acquiring companies with complementary offerings, DENTSPLY SIRONA can expand its product portfolio, strengthen its market position, and accelerate its growth.

Market Cap of $2.75B reflects its significant presence in the dental market.
Gross Margin of 50.9% demonstrates strong pricing power and efficient cost management.
Dividend Yield of 4.65% provides an attractive income stream for investors.
Negative P/E Ratio of -3.11 indicates current profitability challenges, requiring strategic improvements.
Beta of 1.02 suggests market-average volatility.

XRAY提供哪些产品和服务？

Manufactures and sells dental treatment centers.
Provides dental imaging equipment.
Offers motorized dental handpieces and other instruments.
Develops and markets dental CAD/CAM technologies.
Provides dentist-directed clear aligner solutions (SureSmile).
Offers endodontic products for root canal procedures.
Supplies restorative products like artificial teeth and dental ceramics.
Provides small equipment such as intraoral curing lights.

XRAY如何赚钱？

Sells dental equipment and technology to dental professionals and institutions.
Generates revenue from the sale of consumable dental products.
Offers digital dentistry solutions, including CAD/CAM systems and clear aligners.
Provides after-sales service and support for its equipment.

Dental practitioners and specialists.
Dental laboratories.
Hospitals and clinics.
Dental schools and universities.

Established brand reputation and long history in the dental industry.
Extensive product portfolio covering a wide range of dental needs.
Global distribution network providing access to markets worldwide.
Strong relationships with dental professionals and institutions.
Significant investment in research and development, leading to innovative products.

什么因素可能推动XRAY股价上涨？

Ongoing: Increasing adoption of digital dentistry solutions.
Ongoing: Expansion in emerging markets with growing dental care demand.
Upcoming: Launch of new and innovative dental products.
Ongoing: Strategic acquisitions to expand product portfolio and market reach.

XRAY的主要风险是什么？

Ongoing: Intense competition from established players and emerging disruptors.
Potential: Regulatory changes and compliance requirements.
Potential: Product liability claims and recalls.
Ongoing: Economic downturns and reduced consumer spending on dental care.

XRAY的核心优势是什么？

Broad product portfolio covering various dental needs.
Global distribution network and established market presence.
Strong brand reputation and long history in the dental industry.
Continuous innovation in digital dentistry and advanced materials.

XRAY的劣势是什么？

Negative profit margin and declining profitability.
High debt levels and interest expenses.
Exposure to currency fluctuations and economic cycles.
Dependence on third-party distributors in some markets.

XRAY有哪些机遇？

Expansion in emerging markets with growing dental care demand.
Increasing adoption of digital dentistry and clear aligner therapy.
Strategic acquisitions to expand product portfolio and market reach.
Development of new and innovative dental materials and technologies.

XRAY面临哪些威胁？

Intense competition from established players and emerging disruptors.
Regulatory changes and compliance requirements.
Product liability claims and recalls.
Economic downturns and reduced consumer spending on dental care.

XRAY的竞争对手是谁？

Agios Pharmaceuticals Inc — Focuses on hematologic malignancies and rare genetic diseases. — (AGIO)
Beam Therapeutics Inc — Developing precision genetic medicines through base editing. — (BEAM)
Bausch Health Companies Inc — Diversified pharmaceutical company with a broad portfolio. — (BHC)
Cohen & Steers Inc — Investment manager specializing in real assets and alternative income. — (CON)
Haemonetics Corp — Provides blood management solutions to hospitals and blood centers. — (HAE)

Key Metrics

Price: $11.54 (+5.39%)
Market Cap: $3.00B
MoonshotScore: 48/100

Analyst Price Target

Analyst Consensus Target: $15.00
Current Price: $11.54
Implied Upside: +30.0%

Company Profile

CEO: Daniel T. Scavilla
Headquarters: Charlotte, NC, US
Employees: 14,000
Founded: 1987

AI Insight

DENTSPLY SIRONA Inc. manufactures and sells dental products and technologies for the professional dental market. The company operates through two segments: Technologies & Equipment, and Consumables.

常见问题

What does DENTSPLY SIRONA Inc. do?

DENTSPLY SIRONA Inc. is a global leader in the manufacturing and distribution of dental products and technologies. The company operates through two segments: Technologies & Equipment and Consumables, offering a comprehensive range of solutions for dental professionals worldwide. Its products include dental equipment, CAD/CAM systems, clear aligners, endodontic solutions, restorative materials, and small equipment. The company serves dentists, specialists, dental laboratories, and institutions globally, providing essential tools and materials for oral health care.

Is XRAY stock a good buy?

XRAY stock presents a mixed investment picture. While the company possesses a strong market position and a high dividend yield of 4.65%, it currently faces profitability challenges, as indicated by its negative P/E ratio and profit margin. The company's growth potential lies in expanding its digital dentistry offerings and penetrating emerging markets. Investors should carefully weigh the company's turnaround potential against its current financial performance and competitive pressures before making an investment decision.

What are the main risks for XRAY?

DENTSPLY SIRONA faces several key risks, including intense competition from both established players and emerging disruptors in the dental market. Regulatory changes and compliance requirements could also impact the company's operations and profitability. Additionally, product liability claims and recalls pose a potential threat to the company's reputation and financial performance. Economic downturns and reduced consumer spending on dental care could also negatively affect the company's sales and earnings.